Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-06726304 acetate is a selective inhibitor of EZH2, with robust antitumor growth activity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 521,000 |
50 mg | 約10-14 週間 | ¥ 684,000 |
100 mg | 約10-14 週間 | ¥ 918,000 |
説明 | PF-06726304 acetate is a selective inhibitor of EZH2, with robust antitumor growth activity. |
ターゲット&IC50 | EZH2 Y641N:3.0 nM (ki), EZH2 WT:0.7 nM (ki) |
In vitro | PF-06726304 inhibits the proliferation of Karpas-422 cells that harbor wild-type EZH2 (IC50 of 25 nM)[1]. |
In vivo | In a subcutaneous Karpas-422 xenograft model,PF-06726304 inhibits tumor growth and induces robust modulation of downstream biomarkers [1]. |
分子量 | 506.38 |
分子式 | C24H25Cl2N3O5 |
CAS No. | 2080306-28-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-06726304 acetate 2080306-28-9 Chromatin/Epigenetic Histone Methyltransferase PF 06726304 Acetate PF-06726304 Acetate PF 06726304 acetate PF06726304 Acetate PF06726304 acetate Inhibitor inhibitor inhibit